123 related articles for article (PubMed ID: 18585575)
1. Topical budesonide via mucosal atomization device in refractory postoperative chronic rhinosinusitis.
Kanowitz SJ; Batra PS; Citardi MJ
Otolaryngol Head Neck Surg; 2008 Jul; 139(1):131-6. PubMed ID: 18585575
[TBL] [Abstract][Full Text] [Related]
2. Safety of long-term intranasal budesonide delivered via the mucosal atomization device for chronic rhinosinusitis.
Manji J; Singh G; Okpaleke C; Dadgostar A; Al-Asousi F; Amanian A; Macias-Valle L; Finkelstein A; Tacey M; Thamboo A; Javer A
Int Forum Allergy Rhinol; 2017 May; 7(5):488-493. PubMed ID: 28151588
[TBL] [Abstract][Full Text] [Related]
3. The safety and efficacy of short-term budesonide delivered via mucosal atomization device for chronic rhinosinusitis without nasal polyposis.
Thamboo A; Manji J; Szeitz A; Santos RD; Hathorn I; Gan EC; Alsaleh S; Javer AR
Int Forum Allergy Rhinol; 2014 May; 4(5):397-402. PubMed ID: 24449682
[TBL] [Abstract][Full Text] [Related]
4. Effects of systemic steroid treatment in chronic polypoid rhinosinusitis evaluated with magnetic resonance imaging.
Damm M; Jungehülsing M; Eckel HE; Schmidt M; Theissen P
Otolaryngol Head Neck Surg; 1999 Apr; 120(4):517-23. PubMed ID: 10187944
[TBL] [Abstract][Full Text] [Related]
5. Comparison of intranasal fluticasone spray, budesonide atomizer, and budesonide respules in patients with chronic rhinosinusitis with polyposis after endoscopic sinus surgery.
Neubauer PD; Schwam ZG; Manes RP
Int Forum Allergy Rhinol; 2016 Mar; 6(3):233-7. PubMed ID: 26679480
[TBL] [Abstract][Full Text] [Related]
6. [The efficacy and safety of a short course of budesonide inhalation suspension via transnasal nebulization in chronic rhinosinusitis with nasal polyps].
Wang C; Lou H; Lou W; Zhang L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 26(8):347-50. PubMed ID: 22730816
[TBL] [Abstract][Full Text] [Related]
7. Budesonide nasal irrigations in the postoperative management of chronic rhinosinusitis.
Jang DW; Lachanas VA; Segel J; Kountakis SE
Int Forum Allergy Rhinol; 2013 Sep; 3(9):708-11. PubMed ID: 23776108
[TBL] [Abstract][Full Text] [Related]
8. Effect of three-drug delivery modalities on olfactory function in chronic sinusitis.
Reychler G; Colbrant C; Huart C; Le Guellec S; Vecellio L; Liistro G; Rombaux P
Laryngoscope; 2015 Mar; 125(3):549-55. PubMed ID: 25224684
[TBL] [Abstract][Full Text] [Related]
9. Effect of nebulized budesonide on decreasing the recurrence of allergic fungal rhinosinusitis.
Dai Q; Duan C; Liu Q; Yu H
Am J Otolaryngol; 2017; 38(3):321-324. PubMed ID: 28185668
[TBL] [Abstract][Full Text] [Related]
10. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study.
Miehlke S; Madisch A; Karimi D; Wonschik S; Kuhlisch E; Beckmann R; Morgner A; Mueller R; Greinwald R; Seitz G; Baretton G; Stolte M
Gastroenterology; 2009 Jun; 136(7):2092-100. PubMed ID: 19303012
[TBL] [Abstract][Full Text] [Related]
11. [The efficacy of combining antibiotic treatment with topical intranasal steroid administration in the treatment of chronic otitis media with effusion].
Karlidağ T; Kaygusuz I; Gök U; Yalçin S; Keleş E; Oztürk L
Kulak Burun Bogaz Ihtis Derg; 2002; 9(4):257-62. PubMed ID: 12422079
[TBL] [Abstract][Full Text] [Related]
12. Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment.
Valera FC; Queiroz R; Scrideli C; Tone LG; Anselmo-Lima WT
Clin Exp Allergy; 2009 Jan; 39(1):81-8. PubMed ID: 19068102
[TBL] [Abstract][Full Text] [Related]
13. The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study.
Ebbens FA; Georgalas C; Luiten S; van Drunen CM; Badia L; Scadding GK; Hellings PW; Jorissen M; Mullol J; Cardesin A; Bachert C; van Zele TP; Lund VJ; Fokkens WJ
Laryngoscope; 2009 Feb; 119(2):401-8. PubMed ID: 19160404
[TBL] [Abstract][Full Text] [Related]
14. Effect of intranasal budesonide irrigations on intraocular pressure.
Seiberling KA; Chang DF; Nyirady J; Park F; Church CA
Int Forum Allergy Rhinol; 2013 Sep; 3(9):704-7. PubMed ID: 23704078
[TBL] [Abstract][Full Text] [Related]
15. Trial of prophylactic inhaled steroids to prevent or reduce pulmonary function decline, pulmonary symptoms, and airway hyperreactivity in firefighters at the world trade center site.
Banauch GI; Izbicki G; Christodoulou V; Weiden MD; Webber MP; Cohen H; Gustave J; Chavko R; Aldrich TK; Kelly KJ; Prezant DJ
Disaster Med Public Health Prep; 2008 Mar; 2(1):33-9. PubMed ID: 18388656
[TBL] [Abstract][Full Text] [Related]
16. Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper.
Krejci-Manwaring J; McCarty MA; Camacho F; Manuel J; Hartle J; Fleischer A; Feldman SR
J Drugs Dermatol; 2008 Jul; 7(7):643-6. PubMed ID: 18664156
[TBL] [Abstract][Full Text] [Related]
17. Regulation of glucocorticoid receptor in nasal polyps by systemic and intranasal glucocorticoids.
Pujols L; Alobid I; Benítez P; Martínez-Antón A; Roca-Ferrer J; Fokkens WJ; Mullol J; Picado C
Allergy; 2008 Oct; 63(10):1377-86. PubMed ID: 18671773
[TBL] [Abstract][Full Text] [Related]
18. Rhinologic outcomes of concurrent operation for pituitary adenoma and chronic rhinosinusitis: an early experience.
Heo KW; Park SK
Am J Rhinol; 2008; 22(5):533-6. PubMed ID: 18954516
[TBL] [Abstract][Full Text] [Related]
19. Budesonide in the treatment of refractory celiac disease.
Brar P; Lee S; Lewis S; Egbuna I; Bhagat G; Green PH
Am J Gastroenterol; 2007 Oct; 102(10):2265-9. PubMed ID: 17581265
[TBL] [Abstract][Full Text] [Related]
20. Multimodality topical therapy for refractory chronic rhinosinusitis: our experience in thirteen patients with and twelve patients without nasal polyps.
Shikani AH; Kourelis K; Alqudah MA; Shikani HJ; Cope E; Kirk N; Bergstedt D; Basaraba RJ; Leid JG
Clin Otolaryngol; 2013 Jun; 38(3):254-8. PubMed ID: 23398898
[No Abstract] [Full Text] [Related]
[Next] [New Search]
